The 143rd Annual Meeting of the Pharmaceutical Society of Japan (Sapporo)

Session information

Print

Export as PDF

Symposium

[S15] Challenges facing middle molecule drug discovery and how to overcome them

Sun. Mar 26, 2023 1:50 PM - 3:50 PM [Room M1] The Alumni Hall "Frate": Hall (1F)

Organizer: Hiroyuki Miyachi, Katsumi Maenaka

In recent years, organic compounds with a molecular weight of about 500 to 2000, so-called middle molecules, are expected as one of promising drug discovery modalities. In particular, there are great expectations for its usefulness in the creation of pharmaceuticals based on the control of signal transduction, originating from intracellular protein-protein interactions. However, to accelerate middle molecule drug discovery, it is necessary to understand and overcome problems specific to middle molecules. In particular, the low solubility and low membrane permeability of middle molecules are associated with the characteristics of high-molecular compounds such as antibodies. What kind of approach would be effective? There are various chemotypes such as alkaloids, peptides, and oligonucleic acids, even though they are middle molecules. We thought it important to "collect, synthesize, analyze based on a unified method, organize and integrate the results, share and utilize information" of various chemotype medium molecules. Therefore, we developed multifaceted middle molecule research by a heterogeneous group of researchers with different specialties. In this symposium, we will report on these results.

オーガナイザー趣旨説明：宮地 弘幸（東大院薬附属創薬機構） (1:50 PM - 1:52 PM)

総括：宮地 弘幸（東大院薬附属創薬機構） (3:47 PM - 3:50 PM)

×

Authentication

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

×

Please log in with your participant account.
» Participant Log In